Author

M.-C. Vozenin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 3 Approach:experimental assay· 3 Organism:mouse· 3 Assay:bulk RNA-seq· 1

Frequent Co-Authors

A. Almeida· 2 shared B. Petit· 2 shared C. Bailat· 2 shared V. Grilj· 2 shared A. Belhadef· 1 shared A. Llach· 1 shared A.-M. Gomez· 1 shared B. Crozatier· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Almeida

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivApr 20, 2023

Dosimetric and biologic intercomparison between electron and proton FLASH beams

A. Almeida, M. Togno, P. Ballesteros-Zebadua…·M.-c. Vozenin

This study compares the dosimetric and biological effects of electron and proton FLASH beams in mice, finding similar sparing of brain function and tumor control despite differences in beam type and dose rate.

DOI 10.1016/j.radonc.2023.109953

mouseexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintNov 27, 2022

Hypoxic tumors are sensitive to FLASH radiotherapy

R. J. Leavitt, A. Almeida, V. Grilj…·M.-C. Vozenin

This study shows FLASH radiotherapy retains anti-tumor efficacy under extreme hypoxia, overcoming resistance seen with conventional RT.

DOI 10.1101/2022.11.27.518083

mousebulk RNA-seq

𝕏 PostBluesky

PathologybioRxivJun 16, 2021

EPAC1 Inhibition Protects the Heart from Doxorubicin-Induced Toxicity

M. Mazevet, A. Belhadef, M. Ribeiro…·E. Morel

This study shows that inhibiting EPAC1 protects the heart from doxorubicin-induced toxicity without affecting its cancer-killing effects.

DOI 10.7554/elife.83831

mouseexperimental assay

𝕏 PostBluesky